Associated Papers
An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics.
Wolf SJ et al.
The Pharmacogenomics Journal, 2011
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients.
Schaich M et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2009
MDR1 gene polymorphisms and clinical relevance.
Li YH et al.
Yi Chuan Xue Bao = Acta Genetica Sinica, 2006
[Association study between NPY and YWHAH gene polymorphisms and schizophrenia].
Wang HS et al.
Yi Chuan Xue Bao = Acta Genetica Sinica, 2005
[Detecting genetic polymorphisms of CYP1 A1 and GSTM1 simultaneously with oligonucleotide microarray].
Liu SZ et al.
Yi Chuan Xue Bao = Acta Genetica Sinica, 2004
Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors.
Wadelius M et al.
The Pharmacogenomics Journal, 2004
The MDR1 (ABCB1) gene polymorphism and its clinical implications.
Ieiri I et al.
Clinical Pharmacokinetics, 2004
MDR1 genotype-related pharmacokinetics and pharmacodynamics.
Sakaeda T et al.
Biological & Pharmaceutical Bulletin, 2002
Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy.
Brinkmann U et al.
Drug Discovery Today, 2001
[Analysis of association between gene polymorphisms of microsomal epoxide hydrolase (EPHX1) and infant birthweight].
Wu D et al.
Yi Chuan Xue Bao = Acta Genetica Sinica, 2001
[STR polymorphisms in five Chinese ethnic groups(2)].
Li SB et al.
Yi Chuan Xue Bao = Acta Genetica Sinica, 2000
[DNA polymorphisms and haplotypes in the apoAI-CIII gene region and coronary heart disease].
Meng X et al.
Yi Chuan Xue Bao = Acta Genetica Sinica, 1990
Select a paper to view details